Prudential Financial Inc 9 Meters Biopharma, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.26 - $0.64 $3,958 - $9,744
-15,225 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.85 - $1.33 $1,194 - $1,868
-1,405 Reduced 8.45%
15,225 $15,000
Q3 2021

Nov 15, 2021
BUY
$1.03 - $1.41 $3,944 - $5,400
3,830 Added 29.92%
16,630 $22,000
Q2 2021

Aug 16, 2021
BUY
$1.04 - $1.5 $13,312 - $19,200
12,800 New
12,800 $14,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email